✦ LIBER ✦

Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia

✍ Scribed by Kraut, L; Trebeljahr, G; Thiele, B; Fauser, A A

Book ID: 110014758
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 66 KB
Volume: 36
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705125

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Donor cell leukemia in a patient develop

Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia

✍ Selmin Ataergin; Fikret Arpaci; Turker Cetin; Sefik Guran; Cengiz Yakicier; Mura 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

A 10-year median follow-up study after a

A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors

✍ Robin, M; Guardiola, P; Devergie, A; Yeshurun, M; Shapiro, S; Esperou, H; Ribaud 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Inv (11)(p15q21) in donor-derived Ph-neg

Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation

✍ Bruno C. Medeiros; Kathy Chun; Suzanne Kamel-Reid; Jeffrey Lipton 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract Imatinib mesylate (IM) is the standard first‐line treatment for patients with chronic myeloid leukemia (CML). Surprisingly, 2–15% of patients achieving a complete cytogenetic response develop cytogenetic abnormalities in Philadelphia (Ph)‐negative cells. Following hematopoietic stem cel

A retrospective comparison of autologous

A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

✍ Al-Ali, H K; Brand, R; van Biezen, A; Finke, J; Boogaerts, M; Fauser, A A; Egele 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 183 KB

Genome gains at chromosome 21q21/22 segm

Genome gains at chromosome 21q21/22 segment leads to co-amplification of Down Syndrome Critical Regions and known oncogenes in a case of donor cell-derived acute myeloid leukaemia following allogeneic sex mismatched umbilical cord blood transplantation for chronic myeloid leukaemia

✍ Anna Z. Castleton; Diana Brazma; Julie Howard-Reeves; Anastasios Chanalaris; Jul 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB